Navigation Links
As Europe Regulates Probiotics, Americans Need to Know What They're Buying
Date:11/19/2010

BOULDER, Colo., Nov. 19, 2010 /PRNewswire/ -- With the European Union poised to regulate probiotics, and with probiotic supplement sales increasing dramatically in the United States, Americans need to know what they're buying, and how these products can affect their health.

"Currently, there are not these types of regulations in the U.S. As European regulations raise the bar in the probiotic industry world wide, U.S. consumers are still faced with a confusing array of immune system supplements, ingredients and health benefits claims," said Russian-trained microbiologist Dr. Liubov Shynkarenko, a veteran of Soviet Cold War-era bio-chemical warfare research that led to the development of modern probiotics as immune system supplements. "From moderate health imbalances to serious illnesses, different strains and combinations of probiotics will produce different results with liver, heart and other body systems affected by toxicity."

Now Vice President of Research for the Del-Immune V® probiotic product line, Dr. Shynkarenko recommends the following tips for consumers looking to achieve the most effective results from immune system supplements:

  • There are varieties of probiotic strains that can have different effects on each individual. Schedule a micro flora profile with your family health physician or health professional to identify the best kind of probiotic to take based on the specific kinds of bacteria that differ in everyone's body. These strains and combinations efficacy and specificity are what the European Union will be regulating through clinical trials.

  • To ensure that the product you are taking includes live cultures, look at the ingredients. The most popular strains of probiotics today belong to Lactobacillus and Bifidobacterium families. Often, they are only identified on the label by their first initial such as L. or B. Your doctor can help you identify the correct strain for your body and condition.

  • Confirm that it is a legitimate company with a credible website, backed up with extensive research and scientific articles on the products as well as testimonials from customers and healthcare providers.

"With Europe and eventually the U.S. conducting trials and regulating the probiotics industry, better products will be developed, and consumers will have access to more information," said Dr. Shynkarenko. "This will lead to better understanding, and give doctors the knowledge they need to advise patients on the proper strains and combinations of probiotic supplements, which will vary between individuals."

About Del-Immune

Del-Immune V®, manufactured by Lyoferm Inc. in Indiana and distributed by Boulder-based Pure Research Products LLC (PRP), is a probiotic-derived nutritional supplement that provides immediate immune system support. Del-Immune represents the culmination of 30 years of research originated by Cold War-era Soviet Bloc scientists and Russian military bio-warfare troop protection programs. PRP obtained exclusive rights to manufacture, distribute and market the unique Lactobacillus rhamnosus (DV strain) from its Russian partners in 2002. Del-Immune V is used by thousands and recommended by doctors around the world. For more information, please visit http://www.del-immune.com.

Contact:
Jill Thompson
720-833-5921
jthompson@metzger.com



This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Pure Research Products, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
2. Reportlinker Adds European Markets for Wound and Tissue Management 2011
3. Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device
4. SRI International Executive Walter Moos to Discuss Collaborative Pharmaceutical Opportunities with a Nonprofit Organization at BIO-Europe 2010
5. Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer
6. European PACS Market To Attain $512M by 2015
7. Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
8. PAREXEL Expert to Lead Track on Global Clinical Outsourcing at Partnerships in Clinical Trials Europe Conference
9. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
10. Reprints Desk to Highlight New Solution for Scientific, Technical, and Medical Research at Pharma-Bio-Med Conference and Exposition in Europe
11. Drug-Coated Balloons Slowly Making Their Mark on the European Interventional Cardiology Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):